Barchart.com
Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Less than $10/month! View ALL results for your Stocks, ETFs and Funds Screeners with Barchart Plus. FREE 30 Day Trial
Menu
Stocks | Futures | Watchlist | News | More
 
or
Watchlist | Portfolio | Dashboard
Site News
Contact
Market:
Menu

Bridgebio Pharma Inc (BBIO)

Bridgebio Pharma Inc (BBIO)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
News & Headlines for [[ item.sessionDateDisplayLong ]]
Notes
Alerts
Watch
Help
Go To:
BridgeBio Stock Hits 2-Month Highs After Analysts Cheer FDA Nod For Heart Drug: Retail Excitement Builds Stocktwits - Mon Nov 25, 9:06AM CST

Citi noted the positive clinical data and the competitive pricing of Attruby at $225,000 per year, below Pfizer’s tafamidis.

BBIO : 28.76 (-2.51%)
VTI : 299.39 (-0.38%)
XBI : 97.19 (-1.07%)
BridgeBio Pharma Announces FDA Approval of Attrubyâ„¢ to Treat ATTR-CM with Promising Cardiac Outcomes Quiver Quantitative, Inc. - Sat Nov 23, 4:32AM CST

BridgeBio's Attruby is FDA-approved for ATTR-CM, demonstrating significant cardiovascular benefits and providing lifetime free access for trial participants.Quiver AI SummaryBridgeBio Pharma, Inc. announced...

BBIO : 28.76 (-2.51%)
Attruby™ (acoramidis), a Near Complete TTR Stabilizer (≥90%), approved by FDA to Reduce Cardiovascular Death and Cardiovascular-related Hospitalization in ATTR-CM Patients GlobeNewswire - Fri Nov 22, 6:11PM CST

BBIO : 28.76 (-2.51%)
Insider Sale: Chief Executive Officer of $BBIO (BBIO) Sells 1,875 Shares Quiver Quantitative, Inc. - Thu Nov 21, 5:20AM CST

Neil Kumar, the Chief Executive Officer of $BBIO ($BBIO), sold 1,875 shares of the company on 11-19-2024. We received data on the trade from a recent SEC filing. This was a sale of approximately 0.0% of...

BBIO : 28.76 (-2.51%)
Insider Sale: Secretary of $BBIO (BBIO) Sells 4,156 Shares Quiver Quantitative, Inc. - Thu Nov 21, 5:04AM CST

BRIAN C STEPHENSON, the Secretary of $BBIO ($BBIO), sold 4,156 shares of the company on 11-19-2024. We received data on the trade from a recent SEC filing. This was a sale of approximately 4.2% of their...

BBIO : 28.76 (-2.51%)
BridgeBio Pharma Announces Positive 18-Month Results for Infigratinib in Achondroplasia from PROPEL 2 Study Quiver Quantitative, Inc. - Mon Nov 18, 2:56PM CST

Infigratinib shows significant growth improvements in children with achondroplasia, with ongoing trials and FDA breakthrough designations.Quiver AI SummaryBridgeBio Pharma announced positive results from...

BBIO : 28.76 (-2.51%)
Open-Label Extension Data Confirms Sustained Benefit of Acoramidis on Cardiovascular Outcomes, Including Statistically Significant Reduction in ACM Within 36 Months GlobeNewswire - Mon Nov 18, 10:15AM CST

BBIO : 28.76 (-2.51%)
BridgeBio Pharma Announces Publication in the New England Journal of Medicine of Phase 2 PROPEL 2 Study of Infigratinib for Children Living with Achondroplasia GlobeNewswire - Mon Nov 18, 4:30AM CST

BBIO : 28.76 (-2.51%)
BridgeBio Pharma: Q3 Earnings Snapshot AP - Tue Nov 12, 6:40AM CST

BridgeBio Pharma: Q3 Earnings Snapshot

BBIO : 28.76 (-2.51%)
BridgeBio Pharma Reports Third Quarter 2024 Financial Results and Business Update GlobeNewswire - Tue Nov 12, 6:30AM CST

BBIO : 28.76 (-2.51%)

Barchart Exclusives

This Penny Stock Just Surged 380% on a Mega Deal. Is It a Buy, Sell, or Hold? Barchart - 30 minutes ago
LeddarTech is a beaten-down penny stock that is on the move after securing a licensing deal with a semiconductor giant. Read more
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.

Free Barchart Webinar

[[ data.userDate ]]
[[ data.eventTime | date: 'EEE, MMM dd, yyyy h:mm a' ]] [[ zone ]]
Reserve Your Spot